EmpowerCTA injector offers both E-Z-EM’s patented extravasation detection accessory (EDA) and a saline chase. Modular CT injector features air embolism protection, on-the-fly flow rate manipulation, easy syringe loading and arming at the injector. IRiS software tracks: patient ID, creatinine values, GFR, consumable utilization, total contrast filled/injected/wasted, type of contrast, EDA activation status and number of EDA-identified extravasations.

Also featured, the E-Z-EM EmpowerMR injector reportedly provides virtually no injector RF in the scanner room, consistent flow rate delivery, pressure performance on demand, improved productivity and compatibility up to 7T environments.
EmpowerMR employs a hydraulic control system instead of the shielded electrical control components used by most other MR injector systems. EmpowerMR has no shielded iron motors, piezoelectric motors and electrically active motor control circuitry adjacent to the scanner, which significantly minimizes the prospect of electrical interference with the scanner's magnetic field. EmpowerMR is also not battery operated, and links to its electrical supply by a single pass-through cable that does not require special shielding.

E-Z-EM’s VoLumen is a low Hounsfield value oral contrast for MDCT and PET/CT studies designed to overcome the limitations of water and other higher-density positive oral contrasts. It reportedly allows for the simultaneous investigation of all organs, vasculature and surrounding structures of the abdominal/pelvic region and is used in CT Enterography (CTE) for the diagnosis/evaluation of Crohn's disease and other inflammatory bowel disease. It also reportedly minimizes X-ray attenuation, reducing isotope uptake artifacts in PET/CT. VoLumen does not convert to glucose, so it does not interfere with the injection of the glucose-based radioactive contrasts.


Related Content

News | Radiology Business

July 9, 2024 — Bracco and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time July 09, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Breast Imaging

March 8, 2024 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...

Time March 08, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
Feature | Contrast Media Injectors | By Christine Book

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in ...

Time January 17, 2024
arrow
Subscribe Now